CHARLES HUTTON: Open Payments
NPI 1376269175 · THOMASVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 24 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Novo Nordisk Inc | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| SHIELD THERAPEUTICS INC | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
| PFIZER INC. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $16 |
Products named: VRAYLAR, Kerendia, Ozempic, LEQVIO, AIRSUPRA, ACCRUFER, MOUNJARO, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
